Clinical trial
Improving Outcomes in Patients With Kidney Disease Due to Diabetes
NCT00381134 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00381134 |
|---|---|
| Title | Improving Outcomes in Patients With Kidney Disease Due to Diabetes |
| Official title | Improving Outcomes in Diabetic Nephropathy |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes, Kidney Disease, Hypertension |
| Intervention type | Drug |
| Interventions | losartan 100 mg orally once daily, spironolactone 25 mg orally once daily, placebo once orally once daily |
| Enrollment | 92 |
| Start date | Jul 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Sep 27, 2006 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: